Kevin S. Sr. Boyle

CIK 1880600 · Chief Executive Officer · last filed 2023-09-05

Kevin S. Sr. Boyle is a Chief Executive Officer who has filed 7 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $9.5K of TCRT on Sep 5, 2023. Across all open-market trades the lifetime net is +$4.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $10.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$10.1K

Companies

2

Total Filings

7

Lifetime Open-Market Net

$4.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
TCRT	Chief Executive Officer	5,322	$1.90	$10.1K	-$9.5K	4	2023-09-05
Alaunos Therapeutics, Inc. (ZIOP) Delisted	Chief Executive Officer	885,000	$0.87	$766.1K	$14.0K	2	2021-11-17

Recent Filings

7 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-09-05	TCRT	Sell (S)	−68,014	-$9.5K	EDGAR
2023-09-01	TCRT	Notice (144)	−70,401	-$9.5K	EDGAR
2023-03-17	TCRT	Grant (A)	—	$0	EDGAR
2022-09-01	TCRT	Tax (F)	−18,750	-$45.2K	EDGAR
2022-04-01	TCRT	Grant (A)	—	$0	EDGAR
2021-11-17	Alaunos Therapeutics, Inc. (ZIOP) Delisted	Buy (P)	+10,000	$14.0K	EDGAR
2021-08-31	Alaunos Therapeutics, Inc. (ZIOP) Delisted	Grant (A)	+875,000	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.